戻る Agenda
Key Note Session
Session Chair(s)
Tetsuomi Takano, RPh
Editor-in-Chief
Drug R&D Expert, Japan
Speaker(s)
Medicine Development in Japan
Kihito Takahashi
Swedish Orphan Biovitrium (SOBI) Japan, Japan
Head of R&D/Medical Affairs Hub Japan
Outlook for Pharma R&D and Market in China: From RDPAC Viewpoint
Joseph Cho
R&D-based Pharmaceutical Association Committee, China
Managing Director